Genetic factors influencing the development of binding and neutralizing 
antibodies against interferon beta treatment in multiple sclerosis patients

Andlauer, T.F.M.; andlauer, t,; Link, J.; Buck, D.; Ryner, M.; Grummel, V.; Auer, M.; Hegen, H.; Gasperi, C.; Mueller-Myhsok, B.; Jensen, P. E. Hyldgaard; Sellebjerg, F. T.; Kockum, I.; Olsson, T.; Pallardy, M.; Spindeldreher, S.; Deisenhammer, F.; Fogdell-Hahn, A.; Hemmer, B.

Item

ITEM ACTIONSEXPORT

Add to Basket

Release HistoryDetailsSummary

Released

Poster

Genetic factors influencing the development of binding and neutralizing antibodies against interferon beta treatment in multiple sclerosis patients

MPS-Authors

/persons/resource/persons125664

Andlauer, T.F.M.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80450

Mueller-Myhsok, B.
RG Statistical Genetics, Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Andlauer, T., andlauer, t, Link, J., Buck, D., Ryner, M., Grummel, V., et al. (2018). Genetic factors influencing the development of binding and neutralizing antibodies against interferon beta treatment in multiple sclerosis patients. Poster presented at 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, GERMANY.

Cite as: https://hdl.handle.net/21.11116/0000-0003-6FA7-5

Abstract

There is no abstract available